Skip to content

rTMS and Retraining in Focal Hand Dystonia

Effectiveness of rTMS and Retraining in the Treatment of Focal Hand Dystonia

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01738581
Acronym
DSS
Enrollment
9
Registered
2012-11-30
Start date
2011-11-30
Completion date
2015-06-30
Last updated
2019-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Focal Dystonia

Keywords

focal hand dystonia (FHD), repetitive transcranial magnetic stimulation (rTMS), sensorimotor retraining

Brief summary

This study is exploring a new experimental procedure in dystonia called repetitive transcranial magnetic brain stimulation (TMS) combined with rehabilitation. The purpose of the study is to determine whether repetitive TMS is effective as a treatment to reduce symptoms in dystonia as demonstrated by improved motor performance.

Detailed description

BACKGROUND: Though the etiology of focal hand dystonia (FHD) is uncertain, two primary factors implicated in the development of dystonic symptoms are excessive cortical excitability and impaired sensorimotor processing. OBJECTIVE: The purpose of this study was to determine the functional efficacy and neural effects of a Dual intervention of rTMS and sensorimotor retraining. Our working hypothesis is: subjects receiving the combined intervention will (1) display significantly improved handwriting measures; (2) report significant improvement in daily functional ability; (3) display reduced hand cramping compared; and (4) demonstrate reduced corticospinal excitability after the Dual intervention when compared to the rTMS+ stretching and massage (Sham) intervention. METHODS: A randomized, single-subject, multiple baseline design with crossover is used for this study that will examine ten subjects with FHD with two interventions: five days of low-frequency 1 Hz rTMS + sensorimotor retraining (Dual intervention) vs. rTMS + stretching and massage (Sham). The rTMS is applied to the premotor cortex at 1 Hz at 90% resting motor threshold for 1200 pulses. For sensorimotor retraining, a subset of the Learning-based Sensorimotor Training program was followed.

Interventions

DEVICERepetitive Transcranial Magnetic Stimulation

Applied to the premotor cortex at 1 Hz at 90% resting motor threshold for 1200 pulses.

For sensorimotor retraining, a subset of the Learning-based Sensorimotor Training program was followed

BEHAVIORALNon-specific Therapy

A non-specific massage and stretching program directed to the hand, wrist and forearm

Sponsors

University of Minnesota
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Greater than 18 years of age * Symptoms of focal hand dystonia or writer's cramp

Exclusion criteria

* History of seizure or other neurologic disorder

Design outcomes

Primary

MeasureTime frameDescription
Change From Baseline in Global Rating of Change at Posttest (Day 5)Baseline and PosttestSymptom severity was assessed using the global rating of change (GROC). For the GROC, participants were asked to identify between one to three functions most impacted by focal hand dystonia. At posttest 1 they were then asked to select a rating of perceived change that represented the level of function compared to baseline. Perceived change consisted of a ±7 point Likert scale (+7= a very great deal better, 0= no change, -7= a very great deal worse).

Secondary

MeasureTime frameDescription
Change From Baseline in Sensation at Posttest (Day 5)Baseline and PosttestExaminations included two point discrimination. Two-point discrimination threshold was completed using a Disk-Criminator™. Participants were asked to reply one or two after each presentation. Static and dynamic stimuli were presented to the index and ring fingers bilaterally, meaning it was presented as a static stimuli or it was slowly swept across the skin (dynamic).
Change From Baseline in Cortical Silent Period at Posttest (Day 5)Baseline and PosttestCortical silent period (CSP) testing was completed during an isometric contraction of the target muscle whereby the motor evoked potential is followed by a short duration of electromyographic quiescence. The maximal voluntary contraction for finger abduction was recorded using a custom strain gauge placed around the index finger. Real-time visual feedback was given on a laptop screen to project the force produced by the participant and 20% of the maximum of three trials was calculated and displayed on a target line. For the CSP, participants were asked to contract until the target line was met, then a single transcranial magnetic stimulation pulse was delivered to the motor cortex. Ten trials were collected with a short rest period to prevent fatigue. CSP duration was calculated in milliseconds (ms). CSP EMG data were first rectified, and then a 10-ms moving average calculation was applied to the data. The onset of the CSP was set as the time point of the delivery of the TM
Change From Baseline in Arm Dystonia Disability Scale at Posttest (Day 5)Baseline and PosttestThe Arm Dystonia Disability Scale (ADDS) is a survey where participants rate task difficulty for activities such as writing, handling utensils, and buttoning on a scale of 1-4 (1 = no difficulty ,4 = not able or marked difficulty). This is a subjective assessment of impairment due to focal hand dystonia. Scores are determined using an equation: total points scored, divided by the maximum possible (23), multiplied by the quotient by 90 and subtract from 90%. Scores range from 0%-90% with higher scores indicating more function.
Change From Baseline for Physician Rated Impairment at Posttest (Day 5)Baseline and PosttestVideo recordings were made as participants wrote on a pad of paper with pen. Participants were asked to draw a series of 10 loops across the pad of paper followed by The dog is barking and their signature, each repeated four times. A physician blinded to participant allocation rated recordings. Scoring criteria were adapted from a standardized writer's cramp rating scale (WCRS) (Wissel et al., 1996), rating pathological flexion or extension at the wrist, fingers and elbow, presence of tremor, dystonic posture, writing speed and latency of dystonic symptoms. Final scores are expressed as a rating listed as a movement score.
Change From Baseline in Physical Function at Posttest (Day 5)Baseline and PosttestParticipants completed the full SF-36 assessment with subsection of interest: physical functioning.
Change From Baseline for Pressure During Hand Writing at Posttest (Day 5)Baseline and PosttestDigitized handwriting was assessed using a computerized tablet (WACOM Co., Ltd., japan) with MovAlyzeR® (Neuroscript LLC, Tempe, AZ) hardware and software. Participants used a custom modified digitized pen (Kiko Software, Netherlands) to write in a self-selected pace and style on the tablet with real-time visual feedback. Writing tasks included My country tis of thee at a self-selected pace, repeated eight times. Data were sampled at 215 Hz (resolution: 5080 lpi, accuracy: ±0.01 pressure range: 0-800 g). Writing samples were segmented by points of minimal velocity into single strokes for analysis. Pressure for each stroke was automatically calculated within the software.

Countries

United States

Participant flow

Participants by arm

ArmCount
rTMS + Sensorimotor Retraining, rTMS + CTL
Repetitive transcranial magnetic (rTMS) stimulation and sensorimotor retraining for the first phase, then rTMS with control therapy (CTL). CTL therapy was non-specific therapy that includes stretching, massage, range of motion. Repetitive Transcranial Magnetic Stimulation (Magstim): Applied to the premotor cortex at 1 Hz at 80% resting motor threshold for 1200 pulses. Sensorimotor Retraining: For sensorimotor retraining, a subset of the Learning-based Sensorimotor Training program was followed
5
rTMS + CTL, rTMS + Sensorimotor Retraining
Repetitive transcranial magnetic stimulation (rTMS) with control therapy (CTL). CTL therapy was non-specific therapy that includes stretching, massage, range of motion for the first phase, then rTMS with sensorimotor retraining. Repetitive Transcranial Magnetic Stimulation (Magstim): Applied to the premotor cortex at 1 Hz at 80% resting motor threshold for 1200 pulses.
4
Total9

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up10

Baseline characteristics

CharacteristicrTMS + Sensorimotor Retraining, rTMS + CTLrTMS + CTL, rTMS + Sensorimotor RetrainingTotal
Age, Continuous48 years
STANDARD_DEVIATION 13.55359731
44 years
STANDARD_DEVIATION 6.751543034
46 years
STANDARD_DEVIATION 10.64320336
Region of Enrollment
United States
5 participants4 participants9 participants
Sex: Female, Male
Female
2 Participants1 Participants3 Participants
Sex: Female, Male
Male
3 Participants3 Participants6 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
3 / 52 / 4
serious
Total, serious adverse events
0 / 50 / 4

Outcome results

Primary

Change From Baseline in Global Rating of Change at Posttest (Day 5)

Symptom severity was assessed using the global rating of change (GROC). For the GROC, participants were asked to identify between one to three functions most impacted by focal hand dystonia. At posttest 1 they were then asked to select a rating of perceived change that represented the level of function compared to baseline. Perceived change consisted of a ±7 point Likert scale (+7= a very great deal better, 0= no change, -7= a very great deal worse).

Time frame: Baseline and Posttest

Population: All participants who completed the first phase were included in the analysis. Data were only analyzed in the first intervention period of the study because there was a lack of a washout effect between periods. This lack of washout made data from the second intervention period unreliable.

ArmMeasureValue (MEAN)
rTMS With Sensorimotor RetrainingChange From Baseline in Global Rating of Change at Posttest (Day 5)1.3 units on a scale
rTMS With Control TherapyChange From Baseline in Global Rating of Change at Posttest (Day 5)1.2 units on a scale
Secondary

Change From Baseline for Physician Rated Impairment at Posttest (Day 5)

Video recordings were made as participants wrote on a pad of paper with pen. Participants were asked to draw a series of 10 loops across the pad of paper followed by The dog is barking and their signature, each repeated four times. A physician blinded to participant allocation rated recordings. Scoring criteria were adapted from a standardized writer's cramp rating scale (WCRS) (Wissel et al., 1996), rating pathological flexion or extension at the wrist, fingers and elbow, presence of tremor, dystonic posture, writing speed and latency of dystonic symptoms. Final scores are expressed as a rating listed as a movement score.

Time frame: Baseline and Posttest

Population: All participants who completed the first phase were included in the analysis. Data were only analyzed in the first intervention period of the study because there was a lack of a washout effect between periods. This lack of washout made data from the second intervention period unreliable.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
rTMS With Sensorimotor RetrainingChange From Baseline for Physician Rated Impairment at Posttest (Day 5)Improvement2 Participants
rTMS With Sensorimotor RetrainingChange From Baseline for Physician Rated Impairment at Posttest (Day 5)No Change3 Participants
rTMS With Sensorimotor RetrainingChange From Baseline for Physician Rated Impairment at Posttest (Day 5)Worsening0 Participants
rTMS With Control TherapyChange From Baseline for Physician Rated Impairment at Posttest (Day 5)Improvement0 Participants
rTMS With Control TherapyChange From Baseline for Physician Rated Impairment at Posttest (Day 5)No Change3 Participants
rTMS With Control TherapyChange From Baseline for Physician Rated Impairment at Posttest (Day 5)Worsening1 Participants
Secondary

Change From Baseline for Pressure During Hand Writing at Posttest (Day 5)

Digitized handwriting was assessed using a computerized tablet (WACOM Co., Ltd., japan) with MovAlyzeR® (Neuroscript LLC, Tempe, AZ) hardware and software. Participants used a custom modified digitized pen (Kiko Software, Netherlands) to write in a self-selected pace and style on the tablet with real-time visual feedback. Writing tasks included My country tis of thee at a self-selected pace, repeated eight times. Data were sampled at 215 Hz (resolution: 5080 lpi, accuracy: ±0.01 pressure range: 0-800 g). Writing samples were segmented by points of minimal velocity into single strokes for analysis. Pressure for each stroke was automatically calculated within the software.

Time frame: Baseline and Posttest

Population: One participant that did not display symptoms affecting handwriting and did not participate in the handwriting analysis. Data were only analyzed in the first intervention period of the study because there was a lack of a washout effect between periods. This lack of washout made data from the second intervention period unreliable.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
rTMS With Sensorimotor RetrainingChange From Baseline for Pressure During Hand Writing at Posttest (Day 5)Improvement2 Participants
rTMS With Sensorimotor RetrainingChange From Baseline for Pressure During Hand Writing at Posttest (Day 5)No Change3 Participants
rTMS With Sensorimotor RetrainingChange From Baseline for Pressure During Hand Writing at Posttest (Day 5)Worsening0 Participants
rTMS With Control TherapyChange From Baseline for Pressure During Hand Writing at Posttest (Day 5)Improvement2 Participants
rTMS With Control TherapyChange From Baseline for Pressure During Hand Writing at Posttest (Day 5)No Change1 Participants
rTMS With Control TherapyChange From Baseline for Pressure During Hand Writing at Posttest (Day 5)Worsening0 Participants
Secondary

Change From Baseline in Arm Dystonia Disability Scale at Posttest (Day 5)

The Arm Dystonia Disability Scale (ADDS) is a survey where participants rate task difficulty for activities such as writing, handling utensils, and buttoning on a scale of 1-4 (1 = no difficulty ,4 = not able or marked difficulty). This is a subjective assessment of impairment due to focal hand dystonia. Scores are determined using an equation: total points scored, divided by the maximum possible (23), multiplied by the quotient by 90 and subtract from 90%. Scores range from 0%-90% with higher scores indicating more function.

Time frame: Baseline and Posttest

Population: All participants who completed the first phase were included in the analysis. Data were only analyzed in the first intervention period of the study because there was a lack of a washout effect between periods. This lack of washout made data from the second intervention period unreliable.

ArmMeasureValue (MEAN)Dispersion
rTMS With Sensorimotor RetrainingChange From Baseline in Arm Dystonia Disability Scale at Posttest (Day 5)71.98 percentage of functionStandard Deviation 7.031320694
rTMS With Control TherapyChange From Baseline in Arm Dystonia Disability Scale at Posttest (Day 5)71.42 percentage of functionStandard Deviation 8.464086657
Secondary

Change From Baseline in Cortical Silent Period at Posttest (Day 5)

Cortical silent period (CSP) testing was completed during an isometric contraction of the target muscle whereby the motor evoked potential is followed by a short duration of electromyographic quiescence. The maximal voluntary contraction for finger abduction was recorded using a custom strain gauge placed around the index finger. Real-time visual feedback was given on a laptop screen to project the force produced by the participant and 20% of the maximum of three trials was calculated and displayed on a target line. For the CSP, participants were asked to contract until the target line was met, then a single transcranial magnetic stimulation pulse was delivered to the motor cortex. Ten trials were collected with a short rest period to prevent fatigue. CSP duration was calculated in milliseconds (ms). CSP EMG data were first rectified, and then a 10-ms moving average calculation was applied to the data. The onset of the CSP was set as the time point of the delivery of the TM

Time frame: Baseline and Posttest

Population: All participants who completed the first phase were included in the analysis. Data were only analyzed in the first intervention period of the study because there was a lack of a washout effect between periods. This lack of washout made data from the second intervention period unreliable.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
rTMS With Sensorimotor RetrainingChange From Baseline in Cortical Silent Period at Posttest (Day 5)Improvement2 Participants
rTMS With Sensorimotor RetrainingChange From Baseline in Cortical Silent Period at Posttest (Day 5)No Change2 Participants
rTMS With Sensorimotor RetrainingChange From Baseline in Cortical Silent Period at Posttest (Day 5)Worsening1 Participants
rTMS With Control TherapyChange From Baseline in Cortical Silent Period at Posttest (Day 5)Improvement1 Participants
rTMS With Control TherapyChange From Baseline in Cortical Silent Period at Posttest (Day 5)No Change1 Participants
rTMS With Control TherapyChange From Baseline in Cortical Silent Period at Posttest (Day 5)Worsening2 Participants
Secondary

Change From Baseline in Physical Function at Posttest (Day 5)

Participants completed the full SF-36 assessment with subsection of interest: physical functioning.

Time frame: Baseline and Posttest

Population: All participants who completed the first phase were included in the analysis. Data were only analyzed in the first intervention period of the study because there was a lack of a washout effect between periods. This lack of washout made data from the second intervention period unreliable.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
rTMS With Sensorimotor RetrainingChange From Baseline in Physical Function at Posttest (Day 5)No Change4 Participants
rTMS With Sensorimotor RetrainingChange From Baseline in Physical Function at Posttest (Day 5)Improvement1 Participants
rTMS With Sensorimotor RetrainingChange From Baseline in Physical Function at Posttest (Day 5)Worsening0 Participants
rTMS With Control TherapyChange From Baseline in Physical Function at Posttest (Day 5)Improvement0 Participants
rTMS With Control TherapyChange From Baseline in Physical Function at Posttest (Day 5)No Change2 Participants
rTMS With Control TherapyChange From Baseline in Physical Function at Posttest (Day 5)Worsening2 Participants
Secondary

Change From Baseline in Sensation at Posttest (Day 5)

Examinations included two point discrimination. Two-point discrimination threshold was completed using a Disk-Criminator™. Participants were asked to reply one or two after each presentation. Static and dynamic stimuli were presented to the index and ring fingers bilaterally, meaning it was presented as a static stimuli or it was slowly swept across the skin (dynamic).

Time frame: Baseline and Posttest

Population: All participants who completed the first phase were included in the analysis. Data were only analyzed in the first intervention period of the study because there was a lack of a washout effect between periods. This lack of washout made data from the second intervention period unreliable.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
rTMS With Sensorimotor RetrainingChange From Baseline in Sensation at Posttest (Day 5)Worsening0 Participants
rTMS With Sensorimotor RetrainingChange From Baseline in Sensation at Posttest (Day 5)Improvement3 Participants
rTMS With Sensorimotor RetrainingChange From Baseline in Sensation at Posttest (Day 5)No Change2 Participants
rTMS With Control TherapyChange From Baseline in Sensation at Posttest (Day 5)No Change1 Participants
rTMS With Control TherapyChange From Baseline in Sensation at Posttest (Day 5)Improvement2 Participants
rTMS With Control TherapyChange From Baseline in Sensation at Posttest (Day 5)Worsening1 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026